Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes
Acquired copy number alterations in adult acute myeloid leukemia genomes Matthew J. Waltera,b,c,1,2, Jacqueline E. Paytond,1, Rhonda E. Riesa,b,1, William D. Shannona, Hrishikesh Deshmukhd, Yu Zhaoa,b, Jack Batye, Sharon Heatha,b, Peter Westervelta,b,c, Mark A. Watsonc,d, Michael H. Tomassona,b,c, Rakesh Nagarajanc,d, Brian P. O’Garaa,b, Clara D. Bloomfieldf,g, Krzysztof Mro´ zekf,g, Rebecca R. Selzerh, Todd A. Richmondh, Jacob Kitzmanh, Joel Geogheganh, Peggy S. Eish, Rachel Maupini, Robert S. Fultoni, Michael McLellani, Richard K. Wilsoni, Elaine R. Mardisi, Daniel C. Linka,b,c, Timothy A. Grauberta,b,c, John F. DiPersioa,b,c, and Timothy J. Leya,b,c aDepartment of Medicine, bDivision of Oncology, cSiteman Cancer Center, dDepartment of Pathology and Immunology, and eDivision of Biostatistics, Washington University School of Medicine, St. Louis, MO 63110; fDivision of Hematology and Oncology, Department of Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210; gCancer and Leukemia Group B, Chicago, IL 60601; and hRoche NimbleGen, Inc., Madison, WI 53719; and iThe Genome Center, Washington University School of Medicine, St. Louis, MO 63110 Edited by Janet D. Rowley, University of Chicago Medical Center, Chicago, IL, and approved May 18, 2009 (received for review March 23, 2009) Cytogenetic analysis of acute myeloid leukemia (AML) cells has (CNAs) and UPD are common in AML genomes (6–12). However, accelerated the identification of genes important for AML patho- these studies used low-resolution arrays, often used reference DNA genesis. To complement cytogenetic studies and to identify genes that was not obtained from the same patient’s normal cells, and did altered in AML genomes, we performed genome-wide copy num- not routinely validate copy number changes with independent ber analysis with paired normal and tumor DNA obtained from 86 platforms.
[Show full text]